Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
107.8 USD | -0.68% | +2.44% | +16.85% |
06-25 | Blueprint Medicines Insider Sold Shares Worth $7,713,537, According to a Recent SEC Filing | MT |
06-13 | CStone Gets Green Light for Local Manufacturing of AYVAKIT in China | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.85% | 6.8B | |
+38.65% | 39.1B | |
-8.62% | 38.76B | |
+26.95% | 31.24B | |
+10.74% | 25.9B | |
-13.50% | 25.8B | |
+44.87% | 14.06B | |
+34.36% | 13.12B | |
-7.14% | 11.32B | |
-12.61% | 10.68B |
- Stock Market
- Equities
- BPMC Stock
- News Blueprint Medicines Corporation
- Transcript : Blueprint Medicines Corporation Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 04